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Inhibitory natural killer (NK) cell receptors speciﬁc for major histocompatibility complex class I (MHC-I)
molecules include Ly49 receptors in mice and killer immunoglobulin-like receptors (KIR) in humans. The
“licensing” or “arming” models imply that engagement of these receptors to self MHC-I molecules during NK
cell development educates NK cells to be more responsive to cancer and viral infection. We recently reported
that hematopoietic stem cell transplantation (HSCT) induced rapid and preferential expansion of functionally
competent Ly49Gþ, but not other Ly49 family, NK cells independent of NK cell licensing via Ly49eMHC-I
interactions. We now extend these studies to evaluate expression of the two Ly49G receptor isoforms Ly49GB6
and Ly49GBALB, using mice with different MHC-I haplotypes that express one or both of the isoforms. NK cells
from CB6F1 (H-2
bxd) hybrid mice express two different alleles for Ly49G receptor, Ly49GB6 and Ly49GBALB. We
found that CB6F1 mice had more Ly49GB6þ NK cells than Ly49BALBþ NK cells, and that only Ly49GB6þ NK cells
increased in relative numbers and in Ly49G mean ﬂuorescence intensity values after HSCT similar to the B6
parental strain. We further observed that Ly49Gþ NK cells in BALB/c (H-2d) and BALB.B (H-2b) mice, which
have the same background genes, recover slowly after HSCT, in contrast to Ly49Gþ NK cells in B6 (H-2b)
recipients. The difference in expression of Ly49GB6 relative to Ly49GBALB was linked to differences in the
activity of the Pro1 promoter between the two alleles. Thus, we conclude that the Ly49GB6 receptor domi-
nates Ly49G expression on NK cells after HSCT in strains in which that allele is expressed. The data suggest
that Ly49 allelic polymorphism within a particular Ly49 family member can differentially affect NK cell
recovery after HSCT depending on the background genes of the recipient, not on the MHC-I haplotype.
 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.INTRODUCTION Ly49 allelic polymorphism together with the arbitrary
Natural killer (NK) cells provide early immune protection
against pathogens and cancer. NK cells express inhibi-
tory receptors for major histocompatibility complex class I
(MHC-I), Ly49 in mice and killer immunoglobulin-like
receptors (KIRs) in humans, which inhibit NK cell function.
Several models have been proposed to explain the educa-
tional effects of MHC-I molecules on NK cell development,
function, andself-tolerance. If selfMHC-I is down-regulatedor
absent, lack of inhibition triggers “missing self” killing [1]. NK
cells developing in the absence of MHC-I or lacking inhibitory
receptors for self MHC-I are hyporesponsive [2]. The
“licensing,” or “arming,” model implies that NK cells are
initially hyporesponsive and become functionally competent,
or “licensed,” when their Ly49 receptors engage self MHC-I
during NK cell development [3,4]. In addition, the rheostat
model proposes that coexpression of numerous self MHC-
Iespeciﬁc inhibitory receptors in NK cells results in increased
capacity for MHC-Iedependent NK cell function [5].edgments on page 1451.
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generates diversity in the way in which individual NK cells
interact with MHC-I molecules on targets [6,7]. The acqui-
sition of a self MHC-Iespeciﬁc receptor ensures NK cell
tolerance to normal host cells and efﬁcient killing of tumor
and virus-infected cells; however, in humans and mice, the
randomness of receptor distribution also generates NK cells
that have unengaged or no inhibitory MHC-I receptors [3,8],
and it is now known that unengaged Ly49 receptors play
a signiﬁcant role in reducing NK cell function [9]. The ques-
tion of howMHC-I alleles inﬂuence NK cell development and
responsiveness is important to the understanding of hema-
topoietic stem cell transplantation (HSCT) across KIR/human
HLA donorerecipient mismatched barriers, in which donor
NK cells elicit therapeutically beneﬁcial rejection of recipient
leukemic cells [10].
The “licensing,” or “arming,” model has been called into
question recently with our ﬁnding that HSCT induced rapid
and preferential expansion of Ly49Gþ NK cells independent
of the host MHC haplotype [11]. This NK cell subset (unli-
censed in H-2b hosts) was responsible for mediating tumor
killing and critical resistance to mouse cytomegalovirus
(MCMV) infection [11,12]. We sought to extend these studies
to determine whether Ly49G allelic variation can differen-
tially affect NK cell subset recovery after HSCT through theTransplantation. Published by Elsevier Inc. All rights reserved.
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but bearing the same background genes, as well as mice
expressing both Ly49G alleles. We found that CB6F1 (H-2bxd)
hybrid mice had more Ly49GB6þ than Ly49GBALBþ NK cells,
and that only Ly49GB6þ NK cells increased in relative
numbers and in Ly49G mean ﬂuorescent intensity (MFI)
values after HSCT.We also found that Ly49GþNK cells in both
BALB/c (H-2d) and BALB.B (H-2b) hosts recovered slowly after
HSCT, in contrast to Ly49Gþ NK cells in B6 (H-2b) recipients,
indicating that this effect is independent of MHC. Analysis of
Pro1 promoter elements controlling the BALB/c and B6
alleles revealed a more active promoter in the B6 allele,
consistent with the increased subset of NK cells expressing
Ly49GB6. We conclude that the Ly49GB6, but not the
Ly49GBALB, allele dominates Ly49G receptor expression on
NK cells after HSCT. Taken together, these data suggest that
Ly49G allele receptor expression on NK cells is dependent on
allele-speciﬁc differences in control elements and not on self
MHC-I molecules, and that expression of a particular allele
has an impact on reconstitution after HSCT.
METHODS
Mice
Female C57BL/6 (B6, H-2b), Ly5.2 congenic B6 (B6, H-2b), BALB/c (H-2d),
BALB.B (H-2b), and CB6F1 (B6xBALB/c, H-2bxd) hybrid mice were purchased
from Jackson Laboratory (Bar Harbor, ME). All mice were aged 8 to 12 weeks
and were housed in the Animal Facility at the University of Nevada, Reno,
under speciﬁc pathogen-free conditions. All protocols involving animal
work were approved by the Institutional Laboratory Animal Care and Use
Committee. Beginning 1 week before HSCT, the mice received antibiotic
prophylaxis for 4 weeks with ciproﬂoxacin (Ciprobay; Bayer, Munich,
Germany) 100 mg/L of drinking water.
Antibodies
The following ﬂuorochrome-conjugated mAbs and streptavidin
conjugates were purchased from eBioscience (San Diego, CA): Paciﬁc
blue-anti-CD45 (30-F11) and -anti-CD45.1 (A20), R-phycoerythrin
(PE)-Cy7 or -biotinylated anti-CD3 (145-2C11), biotinylated anti-CD122
(TM-b1), allophycocyanin (APC)- or Alexa Fluor 647-anti-NK1.1 (PK136),
and ﬂuorescein isothiocyanate (FITC) anti-Ly49GB6 (Cwy3). PE-anti-
Ly49CI (5E6), FITC-anti-Ly49G2 (4D11) and -anti-Ly49GBALB (AT8),
PE-anti-Ly49A (A1), and FITC-anti-Ly49D (4E5) were purchased from BD
Biosciences (San Jose, CA). Isotype-matched mouse and rat IgG mAbs were
used as negative staining controls. Indirect staining was performed using
APC-conjugated streptavidin (Sav-APC or Sav-APC-Cy7; eBioscience).
Anti-CD32/CD16 antibody (2.4G2; eBioscience) was used to block FcgII/III
receptor-mediated nonspeciﬁc binding.
HSCT
Bone marrow (BM) cells were ﬂushed from femurs and tibias of donors
(Ly5.2 congenic B6, BALB/c, BALB.B, and CB6F1) under aseptic conditions.
Ly5.2 congenic B6 and CB6F1 were treated with 200 mg of anti-NK1.1 mAb
(PK136, in 0.2 mL of PBS in an i.p. injection), and BALB/c and BALB.B with
20 mL of antieasialo-GM1 (1:20 dilution; Wako Chemicals, Richmond, VA) at
2 days before HSCT to deplete donor NK cells before harvest. Single-cell
suspensions were prepared, followed by T cell depletion using anti-Thy1.2
mAb (30H12) and rabbit complement, as described previously [13]. Donor
NK cell and T cell depletion from the BM was conﬁrmed by ﬂow cytometry
assessment using NK1.1 or CD122 with CD3 as discerning markers. The
recipients were exposed to a lethal dose of gamma irradiation from a 137Cs
source (950 cGy for B6, BALB/c, and BALB.B; 1000 cGy for CB6F1). Irradiation
was immediately followed by i.v. injection into the tail vein with congeneic,
syngeneic, or allogeneic hematopoietic stem cells (5106 BM cells in 0.5 mL
of PBS) from sex- and age-matched mice. Each experiment was performed
with 3 or 4 mice per group for each harvest time point.
Cell Preparation and Flow Cytometry
Recipient mice were sacriﬁced at 14 days after HSCT. For ﬂow cytometry,
single-cell splenocyte suspensions were ﬁrst incubated with anti-CD16/
CD32 mAb (clone 2.4G2) from eBioscience (San Diego, CA) to block
nonspeciﬁc antibody binding and then stained with combinations of the
indicated ﬂuorochrome-conjugated or biotinylated mAbs as described
previously [13]. When biotinylated mAbs were used, cells were further
incubated with APC-streptavidin. Stained cells were analyzed with a LSRIIﬂow cytometer (BD Biosciences, San Jose, CA). Data analysis was performed
with FlowJo software (TreeStar, La Jolla, CA). Percentages of donor-derived
NK cells (CD45.1þNK1.1þCD3 [B6; congeneic] and CD45þNK1.1þCD3
[CB6F1; syngeneic] or CD45þCD122þCD3 [BALB/c and BALB.B; syngeneic])
were determined. The MFI of each receptor was deﬁned for the subset of NK
cells expressing the relevant receptor, with MFI values ranging from 0 to
10,000.
Generation of Ly49G Pro1 Core Promoter Luciferase Reporter Plasmids
Promoter fragments were generated by PCR using primers corre-
sponding to the B6 Ly49G pro1 promoter sequence and cloned into the
TOPO-TA vector (Invitrogen, Grand Island, NY). Inserts were excised with
either SacI/XhoI or XhoI/HindIII and cloned into pGL3 (Promega, Madison,
WI) to generate constructs in both forward and reverse orientations. All
constructs were veriﬁed by sequencing with speciﬁc primers.
Cell Transfection and Luciferase Assays
LNK cells were transfected by electroporation with a BTX ECM 830
electroporation system (Gentronics, Welshpool, Australia) set at 250 mV,
with 3 pulses of 7 ms at 100-m intervals. A total of 5  106 cells in 0.5 mL of
serum-free RPMI medium were transfected with 10 mg of the speciﬁc
reporter construct plus 0.1 mg of the Renilla luciferase pRL-SV40 vector.
Luciferase activity was assayed at 48 hours using the Dual-Luciferase
Reporter Assay System (Promega, Madison, WI) according to the manufac-
turer’s instructions. The luciferase activity of the Ly49G Pro1 promoter
constructs was normalized relative to the activity of the Renilla luciferase
produced by the pRL-SV40 control vector, and each construct was tested in
at least 3 independent experiments.
Ly49G Pro1 Transcript Detection by PCR
RNA from spleens obtained at day 7 post-HSCT was extracted using the
RNeasy Mini Kit (Qiagen, Georgetown, MD) following the manufacturer’s
instructions. Here 2 mg of RNA was used to generate cDNA using the
SuperScript First-Strand cDNA Synthesis Kit (Invitrogen). PCR to detect the
Pro1 forward transcript of the Ly49GB6 and Ly49GBALB genes was performed
using 1 mL of cDNA and 35 cycles of (94C for 20 s, 58C for 30 s, and 73C for
20 s). The speciﬁcity of each primer set was conﬁrmed by sequencing of PCR
products. The primer sequences speciﬁc for the Pro1 transcript for each gene
were as follows: Ly49GBALB exon-1a, forward, ACTA-
CAGTCCAAGGATCTGACTAG; Ly49GBALB exon 3, reverse, GCTTCCAGGG-
GACTGAATACTTTC (predicted product size, 292 bp) and Ly49GB6 exon-1a,
forward, AGGATTTCTCATCACAAACTGAAG; Ly49GB6 exon 3, reverse,
GAGCTTCCAGGGGACTGAATACTC (predicted product size, 268 bp). Quanti-
tative PCR was performed with SYBR Green to determine levels of Pro1
transcripts relative to an actin control.
Statistical Analysis
Statistical signiﬁcance was tested using nonparametric tests. P values
<.05 were considered statistically signiﬁcant.
RESULTS
Monoallelic Ly49GB6þ NK Cells Dominate in CB6F1 Hybrid
Mice
Previous studies using Ly49G mAb 4D11 have shown that
Ly49G is a commonly expressed inhibitory receptor on NK
cells, but the expression level varies among different mouse
strains [14]. We ﬁrst conﬁrmed the percentages of Ly49Gþ
NK cells in different mouse strains using the 4D11 mAb,
which binds both allelic isoforms of Ly49G. Ly49Gþ NK cells
composed 45% to 50% of the NK cells in B6 (H-2b) mice
(Figure 1A). The frequency of NK cells expressing the Ly49G
receptor was lower in BALB/c (H-2d) and BALB.B (H-2b) mice
(w20% and 35%, respectively; Figure 1B and C). CB6F1
(H-2bxd) hybrid mice had approximately 35% Ly49Gþ NK
cells, with w 15% Ly49Gdim and w 24% Ly49Gbright cells
(Figure 1D).
Two distinct Ly49G alleles have been identiﬁed in mice
[15]. Using the Ly49G allele-speciﬁc mAbs AT8 (speciﬁc for
Ly49GBALB) and Cwy-3 (binds Ly49GB6), we ﬁrst veriﬁed their
ability to distinguish Ly49G alleles in CB6F1 hybrid mice. As
shown in Figure 1E and F, very few NK cells were biallelic
(w1.7%), andmore NK cells expressed the Ly49GB6 allele than
the Ly49GBALB allele (21.6%  1.2% versus 9.4%  0.61%,
Figure 1. Expression of different Ly49G receptor alleles in NK cells. (A-D) Splenic CD45.1þNK1.1þ/CD122þCD3 NK cells from B6 (H-2b) (A), BALB/c (H-2d) (B), BALB.B
(H-2b) (C), and CB6F1 (B6  BALB/c; H-2bxd) (D) hybrid mice were stained with FITC-anti-Ly49G (4D11). The percentage of cells staining positively and the MFI values
are indicated. (E) Splenic NK cells from CB6F1 mice were stained with FITC-Cwy-3 (Ly49GB6) and PE-AT8 (Ly49GBALB) mAbs. The percentage of cells expressing the
different Ly49G receptor alleles is indicated. (F) Percentages of monoallelic and biallelic NK cells. (G) Intensity levels of Ly49G allele expression. Data are repre-
sentative of 2 or 3 experiments using 3 or 4 mice per group in each experiment (mean  SEM). *P < .05. SSC-A denotes side-scatter area.
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over, monoallelic Ly49GB6 NK cells displayed a higher MFI for
the Ly49G receptor compared with Ly49GBALBþ monoallelic
NK cells (Cwy-3 MFI, 1098  128; AT8 MFI, 357  63; P < .05)
(Figure 1G). Our data indicate that expression of the Ly49G
receptor is differentially regulated in NK cells depending on
the genetic background of the mouse strain.Rapid and Preferential Recovery of Ly49GB6þ NK Cells
Early after HSCT in CB6F1 Hybrid Mice
Murine HSCT models have provided important insights
into NK cell development. We recently reported that NK cells
were the ﬁrst lymphoid cells to repopulate, as early as 7 days
after transplantation in mice, analogous to clinical HSCT [11].
That study showed a preferential expansion of cytotoxic
donor-derived Ly49Gþ NK cells independent of MHC-I
haplotype. In the present study, we extended that previous
study and tested whether this phenomenon occurs in other
mouse strains. Lethally irradiated BALB/c (H-2d), BALB.B (H-
2b), and CB6F1 hybrid mice underwent transplantation with
5106 syngeneic BM cells depleted of NK and T cells. Splenic
Ly49Gþ NK cells were analyzed at day 14 after HSCT.
As shown in Figure 2A, the frequency of Ly49G-expressing
NK cells (4D11þ) was increased signiﬁcantly in CB6F1 recip-
ients after HSCT (44.3%  3.7% versus 35.6%  1.1% in
controls, a 1.3-fold increase; P < .05). Interestingly, after
HSCT, Ly49GB6þ NK cells were present at higher relative
numbers than Ly49GBALBþ NK cells (Ly49GB6þ, 36.5%  2%
versus 21.6%  1.2% in controls [P < .05]; Ly49GBALBþ,
5.23%  0.5% versus 9.4%  0.6% in controls [P < .05];
Ly49GB6:Ly49GBALB ratio, 4.42 [P < .05]) (Figure 2B-D), sug-
gesting that the Ly49GB6þ NK cell subset was selected for
rapid recovery. In addition, only Ly49GB6 NK cells exhibited
increased Ly49G MFI (Cwy-3 MFI, 1778  156 versus1098 128 in controls; P< .05) (Figure 2E). Furthermore, the
frequencies of Ly49Gþ NK cells in BALB/c and BALB.B mice
were markedly reduced after HSCT compared with control
adult resting mice (BALB/c, 13.3%  0.89% versus 19%  2.6%
in controls [P < .05]; BALB.B, 24.8%  1.2% versus
35.5%  0.45% in controls [P < .05]) (Figure 3A, B, and D), and
no changes were noted in the MFI values for Ly49G (BALB/c,
264  25 in controls; BALB.B, 620  14 in controls)
(Figure 3E). This is in contrast to what we reported previ-
ously for the B6 black mouse strains [11], a marked increase
in the frequency and MFI values of Ly49Gþ NK cells
(Figure 3C-E). The percentage of Ly49G-expressing cells at
day 14 post-transplantation was 51.6%  1.5% in B6 mice
compared with 23.6%  0.56% in control mice (P < .05), and
the MFI values of Ly49G (detected by the 4D11 mAb) were
6071  235, compared with 2843  232 in controls (P < .05).
NK cells expressing Ly49A and Ly49D (which also binds
H-2Dd) are present at low frequencies in our HSCT models
[11]. Our data show that the Ly49GB6 allele dominates Ly49G
receptor expression during NK cell reconstitution after HSCT
even in mice expressing both alleles.The Ly49GB6 Allele Contains a Pro1 Promoter Element
That Is More Active Than the Ly49GBALB Pro1 Promoter
Our previous study has shown that Ly49G Pro1 tran-
scription dominates during NK cell reconstitution in B6mice,
providing a molecular explanation for the preferential
expression of Ly49G after HSCT [11]. Thus, we investigated
for allelic differences in the Ly49G Pro1 promoters between
B6 and BALB/c mice that might account for their differential
expression. Figure 4A shows the presence of 2 nucleotide
substitutions in the BALB/c Ly49G Pro1 element compared
with B6. Although the altered nucleotides are not contained
within any of the transcription factor binding sites previously
Figure 2. Ly49GB6þ NK cells dominate in CB6F1 hybrid mice after HSCT. Lethally irradiated CB6F1 (H-2bxd) mice underwent transplantation with 5  106 of syngeneic
NK and T celledepleted HSCs. Splenic CD45.1þNK1.1þCD3 NK cells from recipients were stained with FITC-anti-Ly49G (4D11) (A), FITC-Cwy-3 (Ly49GB6), and PE-AT8
(Ly49GBALB) mAbs (B) at day 14 after syngeneic HSCT and compared with adult resting control mice. The percentage of cells staining positively is indicated in the ﬂow
plots. (C) Percentages of monoallelic and biallelic Ly49Gþ NK cells. (D) Ly49GB6þ:Ly49GBALBþ ratio. (E) Ly49G receptor MFI values. Data are representative of 2
experiments, with 3 mice per group in each experiment (mean  SEM). *P < .05.
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create a potential TATA-binding element that might compete
with the TATA elements required for forward or reverse
transcription from Pro1.
To determine whether the nucleotide changes affect
promoter activity, we cloned the BALB/c and B6 Ly49G Pro1
elements into the pGL3 luciferase reporter vector and then
evaluated promoter activity by transfection into the LNK cell
line. As shown in Figure 4B, the Ly49G Pro1 element from
BALB/c mice exhibited only 50% of the activity of the B6
allele, consistent with the decreased frequency of expression
observed for BALB/c Ly49G. RT-PCR was performed with
primers speciﬁc for either the BALB/c or B6 Ly49g Pro1
forward transcripts using RNA puriﬁed from spleen cells
from either B6 or CB6F1 recipients of CB6F1 BM collected at
7 days post-transplantation (Figure 4C). As predicted by the
2-fold greater activity of the Ly49G Pro1 element, there was
approximately twice as much forward transcript from the
Ly49GB6 allele. Taken together, these results indicate that
allelic differences in the Pro1 promoters of Ly49GB6 and
Ly49GBALB are responsible for the preferential expression of
Ly49GB6 after HSCT.
DISCUSSION
MHC-I molecules play a critical role in NK cell function.
According to the “licensing,” or “arming,” NK education
model, during ontogeny, NK cells are initially hyporesponsive
and become functionally competent, or “licensed,” when
their Ly49 inhibitory receptors engage self MHC-I [3,4].
Functional maturation does not occur in NK cells expressing
exclusively unengaged or no inhibitory MHC-I receptors.
However, this theory of development and receptor acquisi-
tion has been called into question by our recent ﬁnding that
HSCT induced rapid and preferential expansion of Ly49Gþ
NK cells independent of MHC-I haplotype [11]. However, it is
quite possible that Ly49G may be different than the otherLy49 family members and is expressed as a marker for acti-
vation. The Ly49Gþ NK cell subset (unlicensed in H-2b hosts)
was responsible for mediating tumor killing and critical
resistance to MCMV infection, but these effects reﬂect
general activity of the NK cell subpopulations [11,12]. How
NK cell responsiveness is affected by different Ly49G reper-
toires during reconstitution after HSCT remains unknown.
Ly49 allelic polymorphism together with the stochastic
coexpression of MHC-Iespeciﬁc receptors on NK cells
generates diversity in the way in which individual NK cells
interact with MHC-I molecules on targets [6,7]. Based on our
previous ﬁnding that Ly49Gþ NK cells are the primary NK
population that recovers post-HSCT, we examined whether
Ly49G allelic variation could differentially affect NK cell
recovery after HSCT, using strains of mice with different
MHC-I haplotypes. Two distinct Ly49G alleles have been
identiﬁed in mice [15]. We observed that the relative
numbers of Ly49B6þ NK cells (which compose the majority of
the Ly49Gþ NK cells in CB6F1 mice), but not of Ly49BALBþ NK
cells, were signiﬁcantly increased at 14 days after HSCT in
these recipients. Moreover, transplanted BALB/c and BALB.B
mice had lower frequencies of splenic Ly49Gþ NK cells
compared with control adult resting mice, and this NK cell
subset dominated repopulation in B6 recipients after HSCT
[11]. Our data show that the Ly49G alleles Ly49GB6 and
Ly49GBALB are not expressed codominantly in CB6F1 mice,
and that the Ly49GB6 allele dominates Ly49G expression
during NK cell reconstitution after HSCT.
There is evidence of variability in MHC-I ligand recogni-
tion and binding strength of the different Ly49G alleles [17].
The Ly49GBALB receptor more efﬁciently binds to H-2Dd and
H-2Ld comparedwith the Ly49GB6 receptor as determined by
target cell lysis and soluble MHC tetramer binding using
different strains of hybrid mice [18,19]. It is possible that in
our HSCT models, Ly49GBALBþ NK cells that develop in H-2d
hosts have more afﬁnity for H-2Dd than Ly49GBALBþ NK cells
Figure 3. Low frequencies of Ly49GBALBþ NK cells after HSCT. Lethally irradiated C57BL/6 (B6, H-2b, CD45.2) and BALB background mice (H-2d) mice underwent
transplantation with 5  106 of Ly5.2 congenic (H-2b, CD45.1) and syngeneic hematopoietic stem cells depleted of NK and T cells, respectively. (A-C) Splenic
CD45.1þNK1.1þ/CD122þCD3 NK cells from BALB/c (H-2d) (A), BALB.B (H-2b) (B), and B6 (H-2b) (C) mice were stained with FITC-anti-Ly49G (4D11) and PE-anti-Ly49C/
I (5E6) mAbs. The percentages of cells staining positively are indicated. (D) Percentages of Ly49Gþ NK cells. (E) Intensity levels of Ly49G receptor allele expression.
Data are representative of 2 or 3 experiments using 3 or 4 mice per group in each experiment (mean  SEM). *P < .05.
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strong inhibition after Ly49G engagement to ligand and
diminished NK cell recovery. Makrigiannis et al. [15] previ-
ously reported that CB6F1 hybridmice havemore Ly49B6þNK
cells than Ly49BALBþ NK cells, and very few biallelic NK cells.
The presence of H-2Dd ligand in these mice can be a deter-
minant factor for NK cell development, given that hybrid
mice in H-2b and other MHC backgrounds have more Ly49G
biallelic NK cells [20]. However, in CB6F1 mice, NK cells
expressing the Ly49GB6 allele exhibited higher proliferation
in response to IL-2, and NK cells expressing the B6 allele were
capable of activating the BALB/c allele, suggesting that
Ly49GB6 delivers a weaker inhibitory signal than Ly49GBALB
[15]. We found elevated frequencies of Ly49Gþ NK cells in
adult resting BALB.B mice compared with BALB/c mice, along
with a higher MFI for Ly49G. This is likely a consequence of
the lack of self MHC-I in BALB.B mice and the strong binding
of Ly49G to H-2Dd in BALB/c mice, possibly masking
Ly49GBALB expression because of the interaction of cis and
H-2Dd. Ly49GB6þ, but not Ly49GBALBþ, NK cells from CB6F1
hosts exhibited increased Ly49G MFI values. No changes
in MFI values for Ly49G were seen in BALB/c or BALB.B
recipients after transplantation. Of note, HSCT is associated
with a signiﬁcant rise in levels of endogenous cytokines,
including IL-15 and IL-7 [21]. IL-15 in particular is required
for in vivo expansion and survival of NK cells [22]. This may
be why the Ly49G subset dominates after HSCT and activa-
tion in general. The cytokine milieu after HSCT may have
differential effects on the 2 Ly49G alleles, as was seen with
IL-2 stimulation.We previously reported that Ly49Gþ NK cells developing
early after HSCTare cytotoxic against tumors andMCMV [11].
We also reported that both Ly49GB6þ and Ly49GBALBþ NK cell
subsets in CB6F1 hybrid mice displayed lower cytotoxicity
toward H-2Dd targets. However, sorted Ly49GB6þ NK cells
displayed higher cytotoxicity against H-2Dd target cells
compared with Ly49GBALBþ NK cells after IL-2 stimulation
[15]. In the present study, owing to the low frequency of NK
cell subsets developing early after HSCT, it was not possible
to sort cells expressing 1 or both of the Ly49G alleles and to
compare NK cell functional capabilities in the HSCT models
studied. Nevertheless, our data indicate that Ly49G allelic
variation differentially affects NK cell recovery after HSCT.
Ly49A (inhibitory receptor) and Ly49D (activating
receptor) also bind H-2Dd ligands [23]. It is unlikely that
inhibition of NK responses owing to coexpression of Ly49A
with Ly49G accounts for the lack of expansion of Ly49GBALBþ
NK cells, considering that low frequencies of Ly49Aþ NK cells
were present after HSCT in all of the B6 and BALB mouse
strains used [11]. In addition, a previous study found that
Ly49A is expressed equally on Ly49GB6þ and Ly49GBALBþ NK
cells in adult resting CB6F1 hybrid mice [15]. Activation
signaling can override MHC-Iedependent cell inhibition and
increase NK responsiveness [24]. CB6F1 hybrid mice have
more Ly49GBALBþ NK cells expressing Ly49D than Ly49GB6þ
NK cells [15]. It is possible that NK cell activation induced by
Ly49D in H-2d hosts is overridden by inhibitory signals
derived from Ly49GBALB receptor engagement to H-2d (ie,
stronger binding to the ligand compared with the Ly49GB6
receptor). leading to reduced NK cell recovery. The lack of
Figure 4. The Pro1 promoter of Ly49GB6 is more active than the BALB/c allele. Lethally irradiated CB6F1 (H-2bxd) and C57BL/6 (B6, H-2b, CD45.2) mice underwent
transplantation with 5  106 of CB6F1 hematopoietic stem cells depleted of NK and T cells. Splenic RNA was extracted, cDNA was generated, and PCR analysis was
performed. (A) The sequence of the B6 Ly49G Pro1 promoter with 2 nucleotide differences found in the BALB/c allele indicated below. Transcription factor binding
sites shown to play a role in Pro1 activity, as well as a potential TATA element generated by the BALB/c-speciﬁc nucleotides, are indicated by labeled rectangles. (B)
Analysis of BALB/c and B6 Ly49G Pro1 promoter activity in LNK cells. The promoter sequence shown in (A) was cloned in either the forward or reverse orientation into
the pGL3 reporter vector. Values represent the average fold activity relative to an empty vector control, and error bars indicate the standard deviation of at least 3
independent experiments. (C) RT-PCR analysis of BALB/c and B6 Ly49G Pro1 forward transcripts. Splenic RNA was isolated 7 days post-HSCT from either B6 (F1 into
B6) or CB6F1 (F1 into F1) mice receiving a CB6F1 HSCT. PCR with primers speciﬁc for either the BALB/c or B6 Ly49G Pro1 forward were used to amplify 1 mL of cDNA
from each sample, as described in Methods. Three mice were analyzed for each group.
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may be a contributing factor to the diminished NK cell acti-
vation and reduced NK cell recovery after HSCT.
Previous studies of the human KIR3DL1 gene have shown
that allelic differences in the KIR bidirectional promoter can
affect the relative levels of forward versus reverse promoter
activity, and this correlates with differences in the frequency
of NK cells expressing a given allele [25]. In the present study,
we have demonstrated that allelic differences in the Ly49G
Pro1 bidirectional promoter are also associated with changes
in subset expression of Ly49G. The relative promoter activity
of the Ly49G Pro1 elements 129> B6>BALB/c correlateswith
the size of the Ly49Gþ subset found in each strain. Thus, it
would be of interest to determine whether the Ly49G129
allele behaves similarly to the B6 allele in HSCT owing to
a more active Pro1 element, even though it has a greater
afﬁnity for H2Dd, like the BALB/c allele.
NK cells have been under intensive study for their poten-
tial use in HSCT and cancer therapy after reports demon-
strating that use of the appropriate KIR or HLAmismatches in
allogeneic HSCT improved clinical outcomes of patients with
leukemia [26-28]. Ly49 allelic polymorphism and haplotype
size vary in mice, and this situation parallels KIR variability in
humans [29]. Because Ly49 receptor expression in mice (and
KIR expression in humans) is stochastic, an advantage of
allelic polymorphismandheterozygosity is that individualNK
cells havemore receptorswith differentMHC-I speciﬁcities to
choose from during their development in the BM. Whether
human KIR isoforms exist that exhibit these patterns of
differential expression remains to be determined.ACKNOWLEDGMENTS
The authors thank Weihong Ma for excellent technical
support.
Financial disclosure: This project was funded in whole
or in part with federal funds from the National Cancer
Institute, National Institutes of Health, under contract
HHSN261200800001 E. This research was supported by the
Intramural Research Program of the NIH, National Cancer
Institute, Center for Cancer Research.
Conﬂict of interest statement: The authors declare that
there are no conﬂicts of interest.
Authorship statement: I.B. conducted experiments,
analyzed data, and wrote the manuscript. S.K.A and P.W.
conducted experiments, analyzed data, and assisted with
manuscript writing. C.M.S. conducted experiments. D.R. had
experimental oversight and discussed data. W.J.M had
experimental oversight, discussed data, and assisted with
manuscript writing.REFERENCES
1. Ljunggren HG, Karre K. In search of the “missing self”: MHC molecules
and NK cell recognition. Immunol Today. 1990;11:237-244.
2. Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev
Immunol. 2006;6:520-531.
3. Anfossi N, Andre P, Guia S, et al. Human NK cell education by inhibitory
receptors for MHC class I. Immunity. 2006;25:331-342.
4. Kim S, Poursine-Laurent J, Truscott SM, et al. Licensing of natural killer
cells by host major histocompatibility complex class I molecules.
Nature. 2005;436:709-713.
5. Joncker NT, Fernandez NC, Treiner E, et al. NK cell responsiveness is
tuned commensurate with the number of inhibitory receptors for self-
MHC class I: the rheostat model. J Immunol. 2009;182:4572-4580.
I. Barao et al. / Biol Blood Marrow Transplant 19 (2013) 1446e145214526. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell
receptor repertoire. Annu Rev Immunol. 2001;19:291-330.
7. Held W, Coudert JD, Zimmer J. The NK cell receptor repertoire:
formation, adaptation and exploitation. Curr Opin Immunol. 2003;15:
233-237.
8. Fernandez NC, Treiner E, Vance RE, et al. A subset of natural killer cells
achieves self-tolerance without expressing inhibitory receptors speciﬁc
for self-MHC molecules. Blood. 2005;105:4416-4423.
9. Chalifour A, Scarpellino L, Back J, et al. A Role for cis Interaction
between the Inhibitory Ly49A receptor and MHC class I for natural
killer cell education. Immunity. 2009;30:337-347.
10. Ruggeri L, Mancusi A, Capanni M, et al. Donor natural killer cell allor-
ecognition of missing self in haploidentical hematopoietic trans-
plantation for acute myeloid leukemia: challenging its predictive value.
Blood. 2007;110:433-440.
11. Barao I, Alvarez M, Ames E, et al. Mouse Ly49G2þ NK cells dominate
early responses during both immune reconstitution and activation
independently of MHC. Blood. 2011;117:7032-7041.
12. Orr MT, Murphy WJ, Lanier LL. “Unlicensed” natural killer cells domi-
nate the response to cytomegalovirus infection. Nat Immunol. 2010;11:
321-327.
13. Raziuddin A, Longo DL, Bennett M, et al. Increased bone marrow
allograft rejection by depletion of NK cells expressing inhibitory
Ly49 NK receptors for donor class I antigens. Blood. 2002;100:
3026-3033.
14. Ortaldo JR, Mason AT, Winkler-Pickett R, et al. Ly-49 receptor expres-
sion and functional analysis in multiple mouse strains. J Leukoc Biol.
1999;66:512-520.
15. Makrigiannis AP, Rousselle E, Anderson SK. Independent control of
Ly49g alleles: implications for NK cell repertoire selection and tumor
cell killing. J Immunol. 2004;172:1414-1425.
16. Saleh A, Davies GE, Pascal V, et al. Identiﬁcation of probabilistic tran-
scriptional switches in the Ly49 gene cluster: a eukariotic mechanism
for selective gene activation. Immunity. 2004;21:55-66.
17. Johansson S, Johansson M, Rosmaraki E, et al. Natural killer
cell education in mice with single or multiple major histocompatibility
complex class I molecules. J Exp Med. 2005;201:1145-1155.18. Mason LH, Ortaldo JR, Young HA, et al. Cloning and functional char-
acteristics of murine large granular lymphocyte-1: a member of the
Ly-49 gene family (Ly-49G2). J Exp Med. 1995;182:293-303.
19. Hanke T, Takizawa H, McMahon CW, et al. Direct assessment of MHC
class I binding by seven Ly49 inhibitory NK cell receptors. Immunity.
1999;11:67-77.
20. Tanamachi DM, Hanke T, Takizawa H, et al. Expression of natural killer
receptor alleles at different Ly49 loci occurs independently and is
regulated by major histocompatibility complex class I molecules. J Exp
Med. 2001;193:307-315.
21. Miller JS, Soignier Y, Panoskaltsis-Mortari A, et al. Successful adoptive
transfer and in vivo expansion of human haploidentical NK cells in
patients with cancer. Blood. 2005;105:3051-3057.
22. Cooper MA, Bush JE, Fehniger TA, et al. In vivo evidence for a depen-
dence on interleukin 15 for survival of natural killer cells. Blood. 2002;
100:3633-3638.
23. Raulet DH, Held W, Correa I, et al. Speciﬁcity, tolerance and develop-
mental regulation of natural killer cells deﬁned by expression of class
Iespeciﬁc Ly49 receptors. Immunol Rev. 1997;155:41-52.
24. Li H, Pascal V, Martin MP, et al. Genetic control of variegated KIR gene
expression: polymorphisms of the bi-directional KIR3DL1 promoter are
associated with distinct frequencies of gene expression. PLoS Genet.
2008;11:1-11.
25. Diefenbach A, Raulet DH. Strategies for target cell recognition by
natural killer cells. Immunol Rev. 2001;181:170-184.
26. Parham P. MHC class I molecules and KIRs in human history, health and
survival. Nat Rev Immunol. 2005;5:201-214.
27. Yu J, Venstrom JM, Liu XR, et al. Breaking tolerance to self, circulating
natural killer cells expressing inhibitory KIR for non-self HLA exhibit
effector function after T cell-depleted allogeneic hematopoietic cell
transplantation. Blood. 2009;113:3875-3884.
28. Fuchs EJ, Huang XJ, Miller JS. HLA-haploidentical stem cell trans-
plantation for hematologic malignancies. Biol Blood Marrow Transplant.
2010;16:S57-S63.
29. Wilson MJ, Torkar M, Haude A, et al. Plasticity in the organization and
sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA.
2000;97:4778-4783.
